首页> 外文OA文献 >Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group

【2h】

Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group

机译：患者，病变和手术变量是成功进行冠状动脉成形术后腔狭窄再次狭窄的危险因素：对653例778个病变患者的定量分析。预防性腔内冠状动脉阻塞和再狭窄的血管成形术后西拉普利的多中心欧洲研究试验（MERCATOR）研究组

页面导航

著录项
相似文献
相关主题

著录项

作者
Hermans W. R.; Rensing B. J.; Foley D. P.; Tijssen J. G.; Rutsch W.; Emanuelsson H.; Danchin N.; Wijns W.; Chappuis F.; Serruys P. W.;
展开▼
作者单位

展开▼
年度 1993
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Effectiveness and cost effectiveness of single bolus treatment with abciximab (Reo Pro) in preventing restenosis following percutaneous transluminal coronary angioplasty in high risk patients [J] . Mike Aristides, Michael Gliksman, Narayan Rajan Heart . 1998,第1期

机译：abciximab（Reo Pro）单次推注治疗预防高危患者经皮腔内冠状动脉成形术后再狭窄的有效性和成本效益
2. Actual state of radiation exposure during coronary angioplasty: a multicenter study in the nationwide database for cost analysis of percutaneous transluminal coronary angioplasty in Japan. [J] . Yo S, Chino M, Hasegawa T, Circulation journal . 2003,第8期

机译：冠状动脉成形术中辐射暴露的实际状态：日本全国经皮腔内冠状动脉成形术成本分析的多中心研究。
3. Design of a randomized controlled trial of comprehensive rehabilitation in patients with myocardial infarction, stabilized acute coronary syndrome, percutaneous transluminal coronary angioplasty or coronary artery bypass grafting: Akershus Comprehensive Cardiac Rehabilitation Trial (the CORE Study) [J] . Cornel Pater, Carl Ditlef Jacobsen, Arnfinn Rollag, Trials . 2000,第3期

机译：一项针对心肌梗死，稳定的急性冠脉综合征，经皮腔内冠状动脉成形术或冠状动脉搭桥术的患者的全面康复随机对照试验的设计：Akershus全面心脏康复试验（CORE研究）
4. Endothelial dysfunction late after coronary angioplasty: a quantitative coronary angiographic study in patients without restenosis [C] . Vassanelli, C., Turri, . 1992

机译：冠状动脉成形术后晚期内皮功能障碍：无再狭窄患者的定量冠状动脉造影研究
5. Effectiveness and cost-effectiveness of single bolus treatment with abciximab (Reo Pro) in preventing restenosis following percutaneous transluminal coronary angioplasty in high risk patients [O] . M. Aristides, M. Gliksman, N. Rajan, 1998

机译：abciximab（Reo Pro）单次推注预防高危患者经皮腔内冠状动脉成形术后再狭窄的有效性和成本效益
6. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group. [O] . 1992

机译：新的血管紧张素转化酶抑制剂CILAZAPRIL是否会在经皮冠状动脉血管成形术后重新狭窄？ Mercator研究结果：多中心，随机，双盲安慰剂对照试验。血合血管成形术后的多中心欧洲研究试验，以防止透冠状动脉梗阻和再狭窄（MERCOR）研究组。

著录项

相似文献

相关主题

期刊订阅